MIMS to add drug-herb interactions to products

MIMS Australia and IMgateway have announced plans to release a drug herb interactions database for healthcare professionals.

The database has been developed by researchers from the Faculty of Pharmacy at The University of Sydney. The project has been headed up by Professor Basil Roufogalis and Professor Andrew McLachlan, with the database having been maintained and expanded since its inception in 2002.

While the drug-herb interaction information has been made available via the IMgateway website since December 2009, the partnership will deliver the evidence based database to a wider audience by leveraging MIMS Australia’s existing range of products.

MIMS National Business Manager, Margaret Gehrig, said, “It is our intention to work with our clients and partner vendors to deliver this content as part of our integrated data solutions. There is no doubt that the use of complementary medicines is increasing and the need for evidence based information about their impact on prescription medicines is now integral to the needs of healthcare professionals and consumers.”

In a statement, Professor Basil Roufogalis described the signing of the MOU between MIMS and IMgateway as “an important development in the delivery of evidence based information on herbal/nutritional medicine interactions with pharmaceutical drugs. There has been a growing demand for this information from doctors, pharmacists and other health professions. The alliance with MIMS provides an excellent opportunity to disseminate the information developed by the Herbal Medicines Research and Education Centre of the Faculty of Pharmacy more widely and for continuation of the underlying research.”

Posted in Australian eHealth

You need to log in to post comments. If you don't have a Pulse+IT website account, click here to subscribe.

Sign up for Pulse+IT eNewsletters

Sign up for Pulse+IT website access

For more information, click here.

Copyright © 2022 Pulse+IT Communications Pty Ltd
No content published on this website can be reproduced by any person for any reason without the prior written permission of the publisher.
Supported by Social Media Agency | pepperit